DURHAM, NC--(Marketwire - March 03, 2008) - Aldagen, Inc., a biotechnology company advancing a pipeline of clinical-stage regenerative therapies, today announced that David P. Carberry has joined the company as Chief Financial Officer. Mr. Carberry will be responsible for Aldagen’s day-to-day financial operations and corporate financing activities.
